| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xie,Da-Ren | Chairman | 5.83% | |
| Wang,Lu-Yin | Director | 3.46% | |
| Taidoc Technology Corp. | Director | 4.08% | |
| Xie,Ming-Qin | Director | 3.16% | CAREGEN TAIWAN BIOTECH CO., LTD. |
| Yang,Ping-Zheng | Director | 0.22% | |
| Song,Hong-Hong | Director | 0.46% | |
| Zhang,Yi-Shun | Independent Director | 0.00% | |
| Lin,Feng-Hui | Independent Director | 0.00% | |
| Liu,Shi-Gao | Independent Director | 0.00% | |
| Lu,Wen-Xiang | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 21,046 | 51,064 | 27,633 |
| Operating cost | 8,673 | 11,948 | 14,205 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 12,373 | 39,116 | 13,428 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 12,373 | 39,116 | 13,428 |
| Operating expenses | 41,825 | 87,785 | 76,203 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -29,452 | -48,669 | -62,775 |
| Non-operating income and expenses | 3,114 | 7,251 | 1,891 |
| Net profit (loss) before tax | -26,338 | -41,418 | -60,884 |
| Income tax expense (benefits) | 17 | - | - |
| Net profit (loss) of ongoing business for the current period | -26,355 | -41,418 | -60,884 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -26,355 | -41,418 | -60,884 |
| Other comprehensive profit (loss), net | 743 | -1,108 | 880 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -25,612 | -42,526 | -60,004 |
| Net profit (loss) attributable to owners of parent company | -26,355 | -41,418 | -60,884 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Net profit (loss) attributable to non-controlling interests | - | - | 0 |
| Comprehensive profit (loss) attributable to owners of parent company | -25,612 | -42,526 | -60,004 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | 0 |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | 0 |
| Basic earnings per share (yuan) | 0 | 0 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -23,949 | -48,269 | -46,709 |
| Net cash inflows (outflows) from investing activities | -13,611 | -33,594 | -8,987 |
| Net cash inflow (outflow) from financing activities | -2,619 | 345,279 | 304,400 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 742 | -1,102 | 880 |
| Increase (decrease) in cash and cash equivalents in the current period | -39,437 | 262,314 | 249,584 |
| Beginning balance of cash and cash equivalents | 544,160 | 281,846 | 32,262 |
| Ending balance of cash and cash equivalents | 504,723 | 544,160 | 281,846 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 562,198 | 607,813 | 352,397 |
| Non-current asset | 125,565 | 108,928 | 46,132 |
| Total asset | 687,763 | 716,741 | 398,529 |
| Current liability | 14,095 | 14,811 | 12,676 |
| Non-current liability | 13,199 | 15,849 | 7,246 |
| Total liability | 27,294 | 30,660 | 19,922 |
| share capital | 612,182 | 612,182 | 512,182 |
| Equity - secruity token | - | - | - |
| capital reserve | 250,000 | 250,000 | 160,298 |
| retained earning | -200,978 | -174,623 | -293,503 |
| Other equity | -735 | -1,478 | -370 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 660,469 | 686,081 | 378,607 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 660,469 | 686,081 | 378,607 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 10 | 11 | 7 |
